Teva Releases First Breath Activated Asthma Inhaler in U.S.

Traditional corticosteroid inhalers for management of asthma symptoms require patients to squeeze and inhale in a coordinated maneuver. This is surprisingly difficult for many patients who end up receiving sub-optimal treatment. Teva Pharmaceutical, Israel’s big pharma firm, is now releasing in the RediHaler, the first breath-activated corti (Read more...)

Full Story →